Skip to main content
. 2022 Mar 11;12:746643. doi: 10.3389/fonc.2022.746643

Figure 2.

Figure 2

IL-6 promoter methylation level in patients with HBV-associated HCC, CHB and HCs. The IL-6 methylation level was significantly lower in patients with HBV-associated HCC than in those with CHB (p < 0.001) but higher than that in HCs (p = 0.026). Meanwhile, methylation levels of the IL-6 promoter were significantly higher in CHB patients than in healthy controls (P < 0.001) ***p < 0.001, *p < 0.05.